Sort   by:  
 Page size 
UnknownEfficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I.
Not available
S-EPMC4380721 | biostudies-literature
UnknownA pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.
Not available
S-EPMC4800694 | biostudies-literature
UnknownfNIRS reproducibility varies with data quality, analysis pipelines, and researcher experience.
Not available
S-EPMC12322209 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
UnknownA reference human induced pluripotent stem cell line for large-scale collaborative studies.
Not available
S-EPMC9782786 | biostudies-literature
UnknownCentering inclusivity in the design of online conferences-An OHBM-Open Science perspective.
Not available
S-EPMC8377301 | biostudies-literature
UnknownLarge-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
Not available
S-EPMC10942532 | biostudies-literature
UnknownGenome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.
Not available
S-EPMC12635163 | biostudies-literature
UnknownGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977 | biostudies-literature
UnknownGlobal Burden of Cardiovascular Diseases and Risks, 1990-2022.
Not available
S-EPMC7615984 | biostudies-literature
Sort   by:  
 Page size